Evidence map›Paper›PMID 32207148›Full record

ArticleHeadache2020

Behavioral Therapy Preferences in People With Migraine.

Mia T Minen, Adama Jalloh, Olivia Begasse de Dhaem, Elizabeth K Seng

Open access · greenAbstract read
In one paragraph

Article in Headache, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. [Digitalization in headache therapy].Schmerz (Berlin, Germany) · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Mia T MinenDepartments of Neurology and Population Health, NYU Langone Health, New York, NY, USA.
Adama JallohDepartment of Psychology, City College of New York Ringgold Standard Institution, New York, NY, USA.
Olivia Begasse de DhaemDepartment of Neurology, Columbia University, New York, NY, USA.
Elizabeth K SengFerkauf Graduate School of Psychology, Albert Einstein College of Medicine, New York, NY, USA.ORCID 0000-0002-8938-4949
Albert Einstein College of Medicine · USCity College of New York · USColumbia University · USNYU Langone Health · US

Funding

Clinical Decision Support for Patient Migraine ManagementK23NS096107 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SENG-TAMACCIO, ELIZABETH K · 2016 to 2020
$965k
Progressive Muscle Relaxation for Chronic Pain in an Acute Care SettingK23AT009706 · NCCIH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MINEN, MIA · 2018 to 2022
$923k
American Academy of Neuroloigy/American Brain FoundationDoris Duke Fellowship to Retain Clinician ScientistsInternational Headache Academy (IHA)National Center for Complementary and Alternative Medicine K 23 AT009706-01NCCIH NIH HHS K23 AT009706NINDS NIH HHS K23 NS096107
6 · The paper itself

Abstract

backgroundThere are safe and well-tolerated level A evidence-based behavioral therapies for the prevention of migraine. They are biofeedback, cognitive behavioral therapy, and relaxation. However, the behavioral therapies for the prevention of migraine are underutilized.

objectivesWe sought to examine whether people with migraine with 4 or more headache days a month had preferences regarding the type of delivery of the behavioral therapy (in-person, smartphone based, telephone) and whether they would be willing to pay for in-person behavioral therapy. We also sought to determine the predictors of likelihood to pursue the behavioral therapy.

methodsUsing a cross-sectional study design, we developed an online survey using TurkPrime, an online survey platform, to assess how likely TurkPrime participants who screened positive for migraine using the American Migraine Prevalence and Prevention screen were to pursue different delivery methods of the behavioral therapy. We report descriptive statistics and quantitative analyses.

resultsThere were 401 participants. Median age was 34 [IQR: 29, 41] years. More than two thirds of participants (70.3%, 282/401) were women. Median number of headache days/ month was 5 [IQR: 2.83, 8.5]. Some (12.5%, 50/401) used evidence-based behavioral therapy for migraine. The participants reported that they were "somewhat likely" to pursue in-person or smartphone behavioral therapy and behavioral therapy covered by insurance but were neutral about pursuing the telephone-based behavioral therapy. Participants were "not very likely" to pay out of pocket for the behavioral therapy. Migraine-related disability as measured by the MIDAS grading score was associated with likelihood to pursue the behavioral therapy in-person (P = .004), via telephone (P = .015), and via smart phone (P < .001), and covered by insurance (P = .001). However, migraine-related disability was not associated with likelihood to pursue out of pocket (P = .769) behavioral therapy. Pain intensity was predictive of likelihood of pursuing the behavioral therapy for migraine when covered by insurance. Other factors including education, employment, and headache days were not predictors.

conclusionPeople with migraine prefer in-person and smartphone-based behavioral therapy to telephone-based behavioral therapy. Migraine-related disability is associated with likelihood to pursue the behavioral therapy (independent of type of delivery of the behavioral therapy-in-person, telephone based or smartphone based). However, participants were not very likely to pay for the behavioral therapy.

Indexed as

Behavior TherapyInsurance CoveragePatient Acceptance of Health CarePatient PreferenceTelemedicineTelephoneAdultCross-Sectional StudiesFemaleHumansMaleMigraine DisordersSmartphonebiofeedbackcognitive behavioral therapyinsuranceprogressive relaxation therapysmartphonetelephone

Identifiers

PMID32207148
PMCPMC7754245
OpenAlexW3012714048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.